UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903

Bioorganic & medicinal chemistry letters, 2019-01, Vol.29 (2), p.155-159

2019

Volltextzugriff (PDF)

PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells

Cancers, 2021-04, Vol.13 (9), p.2168

2021

Volltextzugriff (PDF)

Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels

ACS chemical neuroscience, 2019-01, Vol.10 (1), p.358-370

2019

Volltextzugriff (PDF)

Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases

Journal of medicinal chemistry, 2019-09, Vol.62 (17), p.7589-7602

2019

Volltextzugriff (PDF)

Nanomedicine in kidney disease

Current opinion in nephrology and hypertension, 2023-07, Vol.32 (4), p.366

2023

Volltextzugriff (PDF)

Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases: Miniperspective

Journal of medicinal chemistry, 2019-09, Vol.62 (17), p.7589-7602

2019

Volltextzugriff (PDF)

An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin

Journal of drug delivery science and technology, 2020-12, Vol.60, p.102021, Article 102021

2020

Volltextzugriff (PDF)

Room temperature N-arylation of amino acids and peptides using copper(I) and β-diketone

Organic & biomolecular chemistry, 2015-04, Vol.13 (16), p.4637-4641

2015

Volltextzugriff (PDF)

Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin

AAPS PharmSciTech, 2020-08, Vol.21 (6), p.226-226, Article 226

2020

Volltextzugriff (PDF)

Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1‐Alkyl‐2‐(pyrrolidin‐1‐yl)‐1 H ‐benzo[ d ]imidazoles as Potent and Selective Inhibitors

ChemMedChem, 2022-07, Vol.17 (14)

2022

Volltextzugriff (PDF)

Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1‐Alkyl‐2‐(pyrrolidin‐1‐yl)‐1H‐benzoimidazoles as Potent and Selective Inhibitors

ChemMedChem, 2022-07, Vol.17 (14)

2022

Volltextzugriff (PDF)

Synthesis and SAR Studies of 1 H -Pyrrolo[2,3- b ]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors

ACS medicinal chemistry letters, 2020-10, Vol.11 (10), p.1848-1854

2020

Volltextzugriff (PDF)

Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1‐Alkyl‐2‐(pyrrolidin‐1‐yl)‐1H‐benzo[d]imidazoles as Potent and Selective Inhibitors

ChemMedChem, 2022-07, Vol.17 (14), p.e202200151-n/a

2022

Volltextzugriff (PDF)

Room temperature N-arylation of amino acids and peptides using copper(i) and β-diketoneElectronic supplementary information (ESI) available: Experimental procedures, product characterization, copies of 1H and 13C and chiral purity studies. See DOI: 10.1039/c5ob00288e

2015-04

Volltextzugriff (PDF)

Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators

Bioorganic & medicinal chemistry letters, 2019-03, Vol.29 (6), p.791-796

2019

Volltextzugriff (PDF)

Synthesis and SAR Studies of 1H‑Pyrrolo[2,3‑b]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors

ACS medicinal chemistry letters, 2020-10, Vol.11 (10), p.1848-1854

2020

Volltextzugriff (PDF)

Synthesis and Biological Characterization of a Series of 2‑Sulfonamidebenzamides as Allosteric Modulators of MrgX1

ACS medicinal chemistry letters, 2022-05, Vol.13 (5), p.841-847

2022

Volltextzugriff (PDF)

Discovery, synthesis and biological characterization of a series of -(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators

RSC medicinal chemistry, 2021-08, Vol.12 (8), p.1366-1373

2021

Volltextzugriff (PDF)

Discovery, synthesis and biological characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators

RSC medicinal chemistry, 2021-08, Vol.12 (8), p.1366-1373

2021

Volltextzugriff (PDF)

Discovery and Characterization of 1 H -Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators

ACS chemical neuroscience, 2017-09, Vol.8 (9), p.1873-1879

2017

Volltextzugriff (PDF)

Discovery and Characterization of 1H‑Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators

ACS chemical neuroscience, 2017-09, Vol.8 (9), p.1873-1879

2017

Volltextzugriff (PDF)

Discovery, synthesis and biological characterization of a series of N -(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1 H -pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators

RSC medicinal chemistry, 2021-08, Vol.12 (8), p.1366-1373

2021

Volltextzugriff (PDF)

ChemInform Abstract: Room Temperature N-Arylation of Amino Acids and Peptides Using Copper(I) and [beta]-Diketone

ChemInform, 2015-08, Vol.46 (33)

2015

Volltextzugriff (PDF)

ChemInform Abstract: Room Temperature N-Arylation of Amino Acids and Peptides Using Copper(I) and β-Diketone

ChemInform, 2015-08, Vol.46 (33), p.no-no

2015

Volltextzugriff (PDF)

A review of FCs integration with microgrid and their control strategies

International journal of hydrogen energy, 2023-11, Vol.48 (91), p.35661-35684

2023

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(50)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(13)
Pharmacology & Pharmacy
(10)
Engineering
(9)
Technology
(9)
Chemistry, Medicinal
(8)
Engineering, Electrical & Electronic
(8)
Microgrids
(8)
Physical Sciences
(7)
Self-Excited Induction Generator
(7)
Control Systems
(6)
Humans
(6)
Power Control
(6)
Battery Energy Storage System
(5)
Chemistry
(5)
Nine Switch Converter
(5)
Nine-Switch Converter
(5)
Photovoltaic System
(5)
Animals
(4)
Boost Converter
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903

PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells

Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels

Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases

Nanomedicine in kidney disease

Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases: Miniperspective

An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin

Room temperature N-arylation of amino acids and peptides using copper(I) and β-diketone

Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin

Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1‐Alkyl‐2‐(pyrrolidin‐1‐yl)‐1 H ‐benzo[ d ]imidazoles as Potent and Selective Inhibitors

Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1‐Alkyl‐2‐(pyrrolidin‐1‐yl)‐1H‐benzoimidazoles as Potent and Selective Inhibitors

Synthesis and SAR Studies of 1 H -Pyrrolo[2,3- b ]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors

Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1‐Alkyl‐2‐(pyrrolidin‐1‐yl)‐1H‐benzo[d]imidazoles as Potent and Selective Inhibitors

Room temperature N-arylation of amino acids and peptides using copper(i) and β-diketoneElectronic supplementary information (ESI) available: Experimental procedures, product characterization, copies of 1H and 13C and chiral purity studies. See DOI: 10.1039/c5ob00288e

Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators

Synthesis and SAR Studies of 1H‑Pyrrolo[2,3‑b]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors

Synthesis and Biological Characterization of a Series of 2‑Sulfonamidebenzamides as Allosteric Modulators of MrgX1

Discovery, synthesis and biological characterization of a series of -(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators

Discovery, synthesis and biological characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators

Discovery and Characterization of 1 H -Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators

Discovery and Characterization of 1H‑Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators

Discovery, synthesis and biological characterization of a series of N -(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1 H -pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators

ChemInform Abstract: Room Temperature N-Arylation of Amino Acids and Peptides Using Copper(I) and [beta]-Diketone

ChemInform Abstract: Room Temperature N-Arylation of Amino Acids and Peptides Using Copper(I) and β-Diketone

A review of FCs integration with microgrid and their control strategies

Suchergebnisse filtern